Scarica l'app Stockscreener
10.46
2.65%
0.27
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$10.19
Aprire:
$10.25
Volume 24 ore:
8.51M
Relative Volume:
0.92
Capitalizzazione di mercato:
$12.05B
Reddito:
$14.33B
Utile/perdita netta:
$-3.79B
Rapporto P/E:
-3.2997
EPS:
-3.17
Flusso di cassa netto:
$1.84B
1 W Prestazione:
-2.43%
1M Prestazione:
+0.67%
6M Prestazione:
+23.35%
1 anno Prestazione:
-21.06%
Intervallo 1D:
$10.15
$10.60
Intervallo di 1 settimana:
$10.15
$10.88
Portata 52W:
$6.85
$13.55
Viatris Inc Stock (VTRS) Company Profile
Nome
Viatris Inc
Settore
Telefono
(724) 514-1465
Indirizzo
1000 MYLAN BOULEVARD, CANONSBURG
Confronta VTRS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VTRS
Viatris Inc
|
10.46 | 11.74B | 14.33B | -3.79B | 1.84B | -3.17 |
|
ZTS
Zoetis Inc
|
122.06 | 51.07B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.30 | 44.42B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.87 | 42.75B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.21 | 27.86B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
474.82 | 20.44B | 3.08B | 1.24B | 1.07B | 25.61 |
Viatris Inc Stock (VTRS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-15 | Iniziato | Truist | Buy |
| 2025-06-06 | Iniziato | Goldman | Neutral |
| 2024-07-19 | Ripresa | Jefferies | Buy |
| 2023-10-23 | Downgrade | BofA Securities | Neutral → Underperform |
| 2023-06-23 | Downgrade | Barclays | Equal Weight → Underweight |
| 2023-04-24 | Downgrade | Barclays | Overweight → Equal Weight |
| 2023-02-17 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2023-01-27 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-11-10 | Aggiornamento | UBS | Sell → Neutral |
| 2022-11-08 | Aggiornamento | Piper Sandler | Underweight → Neutral |
| 2022-10-21 | Ripresa | Jefferies | Hold |
| 2022-06-14 | Iniziato | UBS | Sell |
| 2022-05-10 | Downgrade | Piper Sandler | Neutral → Underweight |
| 2022-03-01 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-03-01 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2021-06-15 | Iniziato | Citigroup | Neutral |
| 2021-04-07 | Ripresa | RBC Capital Mkts | Outperform |
| 2021-03-08 | Downgrade | Goldman | Buy → Neutral |
| 2021-03-02 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-02-26 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2021-01-05 | Iniziato | Argus | Hold |
| 2020-12-14 | Iniziato | Bernstein | Mkt Perform |
Mostra tutto
Viatris Inc Borsa (VTRS) Ultime notizie
Pfizer, UnitedHealth, Viatris, Addus HomeCare, and Quest Stocks Trade Up, What You Need To Know - Finviz
Is Viatris Inc. (VIA) stock inflation resilientJuly 2025 Price Swings & Verified Trade Idea Suggestions - newser.com
Can Viatris Inc. (VIA) stock sustain double digit ROETrade Risk Report & Long-Term Safe Investment Plans - newser.com
What market sentiment indicators show for Viatris Inc. (VIA) stockJuly 2025 Spike Watch & Real-Time Stock Entry Alerts - newser.com
Can Viatris Inc. (VIA) stock test all time highsJuly 2025 Sector Moves & Fast Exit Strategy with Risk Control - newser.com
(VTRS) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com
Ex-Dividend Reminder: Viatris, Radian Group and Equitable Holdings - Nasdaq
European study shows falling prices, rising costs and shortagesfindings from independent study presented during World AMR Awareness Week by Viatris and Medicines for Europe | Corporate - EQS News
Is Viatris Inc. stock supported by strong cash flowsInsider Buying & Comprehensive Market Scan Insights - newser.com
How Viatris Inc. (VIA) stock trades pre earningsQuarterly Profit Report & Comprehensive Market Scan Insights - newser.com
Europäische Studie zeigt sinkende Preise, steigende Kosten und EngpässeErgebnisse einer unabhängigen Studie, die während der World AMR Awareness Week von Viatris und Medicines for Europe vorgestellt wurden - PR Newswire
Is it time to cut losses on Viatris Inc.Weekly Trend Recap & Real-Time Stock Entry Alerts - newser.com
Is Viatris Inc. stock recession proof2025 Price Momentum & Risk Controlled Daily Trade Plans - newser.com
What technical charts say about Viatris Inc. stockJuly 2025 Closing Moves & Safe Capital Growth Stock Tips - newser.com
Will Viatris Inc. (VIA) stock benefit from commodity supercycle2025 Price Targets & Entry Point Confirmation Alerts - newser.com
Why Viatris Inc. stock could be next big winnerJuly 2025 Breakouts & Detailed Earnings Play Strategies - newser.com
Will Viatris Inc. stock recover faster than peersMarket Trend Review & Risk Adjusted Buy and Sell Alerts - newser.com
Can Viatris Inc. (VIA) stock surprise markets with earningsInflation Watch & Safe Entry Point Identification - newser.com
United States General Anesthesia Drugs Market Insights & Growth - openPR.com
What dividend safety score for Viatris Inc. stockJuly 2025 Spike Watch & Low Risk Profit Maximizing Plans - newser.com
Viatris Inc. stock outlook for YEARTrend Reversal & Fast Exit/Entry Strategy Plans - newser.com
Using AI based signals to follow Viatris Inc.2025 Key Lessons & Real-Time Buy Zone Alerts - newser.com
Viatris Inc. - Ad-hoc-news.de
Viatris Inc. (0A5V.L) Stock Price, News, Quote & History - Yahoo! Finance Canada
Is Viatris Inc. stock a good choice for value investorsWeekly Risk Summary & Growth Focused Stock Reports - newser.com
What does recent volatility data suggest for Viatris Inc.Oil Prices & Growth Focused Stock Reports - newser.com
Viatris at Jefferies Conference: Strategic Growth Plans - Investing.com India
Viatris Wins EU Nod For Teduglutide Generic - Citeline News & Insights
Viatris Inc Azioni (VTRS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):